{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T21:54:15Z","timestamp":1783979655895,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00467-025-07118-0","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T01:39:14Z","timestamp":1767836354000},"page":"2415-2424","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy of mycophenolate mofetil versus cyclophosphamide in the management of childhood-onset lupus nephritis: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"41","author":[{"given":"Subhankar","family":"Sarkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaushik","family":"Mukhopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mita","family":"Mandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Bhowmick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niladri Sekhar","family":"Bhunia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rimjhim","family":"Sonowal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vineet Kumar","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish Chandra","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3763-6905","authenticated-orcid":false,"given":"Nihar Ranjan","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"issue":"Suppl 1","key":"7118_CR1","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2023.09.002","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Lupus Nephritis Work Group","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Lupus Nephritis Work Group (2024) KDIGO 2024 Clinical Practice Guideline for the management of lupus nephritis. Kidney Int 105(Suppl 1):S1\u2013S69. https:\/\/doi.org\/10.1016\/j.kint.2023.09.002","journal-title":"Kidney Int"},{"key":"7118_CR2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.rdc.2009.12.012","volume":"36","author":"R Mina","year":"2010","unstructured":"Mina R, Brunner HI (2010) Pediatric lupus\u2014are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus? Rheum Dis Clin North Am 36:53\u201380. https:\/\/doi.org\/10.1016\/j.rdc.2009.12.012","journal-title":"Rheum Dis Clin North Am"},{"key":"7118_CR3","doi-asserted-by":"publisher","first-page":"sfae212","DOI":"10.1093\/ckj\/sfae212","volume":"17","author":"F Peyronel","year":"2024","unstructured":"Peyronel F, Rossi GM, Palazzini G, Odone L, Errichiello C, Emmi G et al (2024) Early-onset lupus nephritis. Clin Kidney J 17:sfae212. https:\/\/doi.org\/10.1093\/ckj\/sfae212","journal-title":"Clin Kidney J"},{"key":"7118_CR4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ekir.2022.10.014","volume":"8","author":"EY Chan","year":"2022","unstructured":"Chan EY, Yap DY, Wong WT, Wong WH, Wong SW, Lin KY et al (2022) Long-term outcomes of children and adolescents with biopsy-proven childhood-onset lupus nephritis. Kidney Int Rep 8:141\u2013150. https:\/\/doi.org\/10.1016\/j.ekir.2022.10.014","journal-title":"Kidney Int Rep"},{"key":"7118_CR5","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00467-021-05164-y","volume":"37","author":"S Qiu","year":"2022","unstructured":"Qiu S, Zhang H, Yu S, Yang Q, Zhang G, Yang H et al (2022) Clinical manifestations, prognosis, and treat-to-target assessment of pediatric lupus nephritis. Pediatr Nephrol 37:367\u2013376. https:\/\/doi.org\/10.1007\/s00467-021-05164-y","journal-title":"Pediatr Nephrol"},{"key":"7118_CR6","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1007\/s00467-006-0052-3","volume":"21","author":"SN Wong","year":"2006","unstructured":"Wong SN, Tse KC, Lee TL, Lee KW, Chim S, Lee KP et al (2006) Lupus nephritis in Chinese children\u2014a territory-wide cohort study in Hong Kong. Pediatr Nephrol 21:1104\u20131112. https:\/\/doi.org\/10.1007\/s00467-006-0052-3","journal-title":"Pediatr Nephrol"},{"key":"7118_CR7","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1177\/0961203308097570","volume":"18","author":"P Hari","year":"2009","unstructured":"Hari P, Bagga A, Mahajan P, Dinda A (2009) Outcome of lupus nephritis in Indian children. Lupus 18:348\u2013354. https:\/\/doi.org\/10.1177\/0961203308097570","journal-title":"Lupus"},{"key":"7118_CR8","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s00467-022-05769-x","volume":"38","author":"P Khandelwal","year":"2023","unstructured":"Khandelwal P, Govindarajan S, Bagga A (2023) Management and outcomes in children with lupus nephritis in the developing countries. Pediatr Nephrol 38:987\u20131000. https:\/\/doi.org\/10.1007\/s00467-022-05769-x","journal-title":"Pediatr Nephrol"},{"key":"7118_CR9","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1002\/art.1780340803","volume":"34","author":"AD Steinberg","year":"1991","unstructured":"Steinberg AD, Steinberg SC (1991) Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only. Arthritis Rheum 34:945\u2013950. https:\/\/doi.org\/10.1002\/art.1780340803","journal-title":"Arthritis Rheum"},{"key":"7118_CR10","doi-asserted-by":"publisher","first-page":"549","DOI":"10.7326\/0003-4819-125-7-199610010-00003","volume":"125","author":"MF Gourley","year":"1996","unstructured":"Gourley MF, Austin HA, Scott D, Yarboro CH, Vaughan EM, Muir J et al (1996) Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis: a randomized, controlled trial. Ann Intern Med 125:549\u2013557. https:\/\/doi.org\/10.7326\/0003-4819-125-7-199610010-00003","journal-title":"Ann Intern Med"},{"key":"7118_CR11","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/1756-185X.12423","volume":"18","author":"DY Yap","year":"2015","unstructured":"Yap DY, Chan TM (2015) Treatment of lupus nephritis: practical issues in Asian countries. Int J Rheum Dis 18:138\u2013145. https:\/\/doi.org\/10.1111\/1756-185X.12423","journal-title":"Int J Rheum Dis"},{"key":"7118_CR12","doi-asserted-by":"publisher","first-page":"8345737","DOI":"10.1155\/2022\/8345737","volume":"2022","author":"XY Quan","year":"2022","unstructured":"Quan XY, Chen HT, Liang SQ, Yang C, Yao CW, Xu YZ et al (2022) Revisited cyclophosphamide in the treatment of lupus nephritis. BioMed Res Int 2022:8345737. https:\/\/doi.org\/10.1155\/2022\/8345737","journal-title":"BioMed Res Int"},{"key":"7118_CR13","doi-asserted-by":"publisher","first-page":"366","DOI":"10.7326\/0003-4819-119-5-199309010-00003","volume":"119","author":"DT Boumpas","year":"1993","unstructured":"Boumpas DT, Austin HA, Vaughan EM, Yarboro CH, Klippel JH, Balow JE (1993) Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy. Ann Intern Med 119:366\u2013369. https:\/\/doi.org\/10.7326\/0003-4819-119-5-199309010-00003","journal-title":"Ann Intern Med"},{"key":"7118_CR14","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/ki.2015.318","volume":"89","author":"M Rathi","year":"2016","unstructured":"Rathi M, Goyal A, Jaryal A, Sharma A, Gupta PK, Ramachandran R et al (2016) Comparison of low-dose intravenous cyclophosphamide with oral mycophenolate mofetil in the treatment of lupus nephritis. Kidney Int 89:235\u2013242. https:\/\/doi.org\/10.1038\/ki.2015.318","journal-title":"Kidney Int"},{"key":"7118_CR15","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s40744-023-00595-5","volume":"10","author":"Q Guo","year":"2023","unstructured":"Guo Q, Zhang X, Sun S, Tang X, Shen W, Liang J et al (2023) Association between mycophenolate mofetil use and subsequent infections among hospitalized patients with systemic lupus erythematosus: a nested case-control study. Rheumatol Ther 10:1535\u20131554. https:\/\/doi.org\/10.1007\/s40744-023-00595-5","journal-title":"Rheumatol Ther"},{"key":"7118_CR16","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1034\/j.1399-3046.2002.00021.x","volume":"6","author":"VR Dharnidharka","year":"2002","unstructured":"Dharnidharka VR, Ho PL, Stablein DM, Harmon WE, Tejani AH (2002) Mycophenolate, tacrolimus and post-transplant lymphoproliferative disorder: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant 6:396\u2013399. https:\/\/doi.org\/10.1034\/j.1399-3046.2002.00021.x","journal-title":"Pediatr Transplant"},{"key":"7118_CR17","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","volume":"10","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev 10:89. https:\/\/doi.org\/10.1186\/s13643-021-01626-4","journal-title":"Syst Rev"},{"key":"7118_CR18","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1056\/NEJM197811232992102","volume":"299","author":"JV Donadio Jr","year":"1978","unstructured":"Donadio JV Jr, Holley KE, Ferguson RH, Ilstrup DM (1978) Treatment of diffuse proliferative lupus nephritis with prednisone and combined prednisone and cyclophosphamide. N Engl J Med 299:1151\u20131155","journal-title":"N Engl J Med"},{"key":"7118_CR19","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"EM Tan","year":"1982","unstructured":"Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271\u20131277. https:\/\/doi.org\/10.1002\/art.1780251101","journal-title":"Arthritis Rheum"},{"key":"7118_CR20","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725. https:\/\/doi.org\/10.1002\/art.1780400928","journal-title":"Arthritis Rheum"},{"key":"7118_CR21","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","volume":"64","author":"M Petri","year":"2012","unstructured":"Petri M, Orbai AM, Alarc\u00f3n GS, Gordon C, Merrill JT, Fortin PR et al (2012) Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64:2677\u20132686. https:\/\/doi.org\/10.1002\/art.34473","journal-title":"Arthritis Rheum"},{"key":"7118_CR22","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","volume":"78","author":"M Aringer","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R et al (2019) 2019 European league against rheumatism\/American college of rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis 78:1151\u20131159. https:\/\/doi.org\/10.1136\/annrheumdis-2018-214819","journal-title":"Ann Rheum Dis"},{"key":"7118_CR23","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s40620-022-01438-2","volume":"36","author":"M Chbihi","year":"2023","unstructured":"Chbihi M, Eveillard LA, Riller Q, Brousse R, Berthaud R, Quartier P et al (2023) Induction therapy for pediatric onset class IV lupus nephritis: mycophenolate mofetil versus cyclophosphamide. J Nephrol 36:829\u2013839. https:\/\/doi.org\/10.1007\/s40620-022-01438-2","journal-title":"J Nephrol"},{"key":"7118_CR24","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.jmii.2023.08.003","volume":"56","author":"HG Chen","year":"2023","unstructured":"Chen HG, Chen JS, Chen YS, Yin CH, Chen HC, Chiou YH (2023) Comparison of mycophenolic acid with cyclophosphamide for the treatment of pediatric lupus nephritis: a retrospective study from a tertiary center hospital in Taiwan. J Microbiol Immunol Infect 56:1105\u20131113. https:\/\/doi.org\/10.1016\/j.jmii.2023.08.003","journal-title":"J Microbiol Immunol Infect"},{"key":"7118_CR25","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12969-018-0279-0","volume":"16","author":"JC Cooper","year":"2018","unstructured":"Cooper JC, Rouster-Stevens K, Wright TB, Hsu JJ, Klein-Gitelman MS, Ardoin SP et al (2018) Pilot study comparing the Childhood Arthritis and Rheumatology Research Alliance consensus treatment plans for induction therapy of juvenile proliferative lupus nephritis. Pediatr Rheumatol Online J 16:65. https:\/\/doi.org\/10.1186\/s12969-018-0279-0","journal-title":"Pediatr Rheumatol Online J"},{"key":"7118_CR26","doi-asserted-by":"publisher","unstructured":"Wisanuyotin S, Pattaragarn A, Chanakul A, Lumpaopong A, Chartapisak W (2020) Outcomes of mycophenolate mofetil vs. intravenous cyclophosphamide in induction therapy of childhood-onset lupus nephritis. J Med Assoc Thai 103:785\u2013790. https:\/\/doi.org\/10.35755\/jmedassocthai.2020.08.11180","DOI":"10.35755\/jmedassocthai.2020.08.11180"},{"key":"7118_CR27","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1177\/0961203319836712","volume":"28","author":"E Smith","year":"2019","unstructured":"Smith E, Al-Abadi E, Armon K, Bailey K, Ciurtin C, Davidson J et al (2019) Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis. Lupus 28:613\u2013620. https:\/\/doi.org\/10.1177\/0961203319836712","journal-title":"Lupus"},{"key":"7118_CR28","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.pedhc.2007.07.006","volume":"22","author":"KK Lau","year":"2008","unstructured":"Lau KK, Ault BH, Jones DP, Butani L (2008) Induction therapy for pediatric focal proliferative lupus nephritis: cyclophosphamide versus mycophenolate mofetil. J Pediatr Health Care 22:282\u2013288. https:\/\/doi.org\/10.1016\/j.pedhc.2007.07.006","journal-title":"J Pediatr Health Care"},{"key":"7118_CR29","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1177\/0961203312458466","volume":"21","author":"R Sundel","year":"2012","unstructured":"Sundel R, Solomons N, Lisk L (2012) Efficacy of mycophenolate mofetil in adolescent patients with lupus nephritis: evidence from a two-phase, prospective randomized trial. Lupus 21:1433\u20131443. https:\/\/doi.org\/10.1177\/0961203312458466","journal-title":"Lupus"},{"key":"7118_CR30","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1007\/s00467-012-2164-4","volume":"27","author":"SH Lee","year":"2012","unstructured":"Lee SH, Kang HG, Ha IS, Cheong HI (2012) The efficacy of mycophenolate mofetil in children with lupus nephritis: a preliminary study. Pediatr Nephrol 27:1441\u20131447. https:\/\/doi.org\/10.1007\/s00467-012-2164-4","journal-title":"Pediatr Nephrol"},{"key":"7118_CR31","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1002\/art.10534","volume":"46","author":"HI Brunner","year":"2002","unstructured":"Brunner HI, Silverman ED, To T, Bombardier C, Feldman BM (2002) Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage. Arthritis Rheum 46:436\u2013444. https:\/\/doi.org\/10.1002\/art.10534","journal-title":"Arthritis Rheum"},{"key":"7118_CR32","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12969-021-00627-w","volume":"19","author":"M Gilbert","year":"2021","unstructured":"Gilbert M, Goilav B, Hsu JJ, Wright TB, Ardoin SP, Rouster-Stevens K et al (2021) Differences in rituximab use between pediatric rheumatologists and nephrologists for the treatment of refractory lupus nephritis and renal flare in childhood-onset SLE. Pediatr Rheumatol 19:137. https:\/\/doi.org\/10.1186\/s12969-021-00627-w","journal-title":"Pediatr Rheumatol"},{"key":"7118_CR33","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1177\/09612033231202843","volume":"32","author":"D Biswas","year":"2023","unstructured":"Biswas D, Dasgupta D, Pal P, Sinha R (2023) Presentation and outcome of pediatric lupus nephritis from a large single centre contemporary cohort in Eastern India. Lupus 32:1440\u20131446. https:\/\/doi.org\/10.1177\/09612033231202843","journal-title":"Lupus"},{"key":"7118_CR34","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1007\/s00467-023-06018-5","volume":"38","author":"C De Mutiis","year":"2023","unstructured":"De Mutiis C, Wenderfer SE, Basu B et al (2023) International cohort of 382 children with lupus nephritis \u2013 presentation, treatment and outcome at 24 months. Pediatr Nephrol 38:3699\u20133709. https:\/\/doi.org\/10.1007\/s00467-023-06018-5","journal-title":"Pediatr Nephrol"},{"key":"7118_CR35","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1177\/0961203309357763","volume":"19","author":"YH Lee","year":"2010","unstructured":"Lee YH, Woo JH, Choi SJ, Ji JD, Song GG (2010) Induction and maintenance therapy for lupus nephritis: a systematic review and meta-analysis. Lupus 19:703\u2013710. https:\/\/doi.org\/10.1177\/0961203309357763","journal-title":"Lupus"},{"key":"7118_CR36","doi-asserted-by":"publisher","first-page":"e22328","DOI":"10.1097\/MD.0000000000022328","volume":"99","author":"YP Jiang","year":"2020","unstructured":"Jiang YP, Zhao XX, Chen RR, Xu ZH, Wen CP, Yu J (2020) Comparative efficacy and safety of mycophenolate mofetil and cyclophosphamide in the induction treatment of lupus nephritis: a systematic review and meta-analysis. Medicine (Baltimore) 99:e22328. https:\/\/doi.org\/10.1097\/MD.0000000000022328","journal-title":"Medicine (Baltimore)"},{"key":"7118_CR37","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1053\/j.ajkd.2016.12.008","volume":"70","author":"SC Palmer","year":"2017","unstructured":"Palmer SC, Tunnicliffe DJ, Singh-Grewal D, Craig JC, Tong A, O\u2019Connell PJ et al (2017) Induction and maintenance immunosuppression treatment of proliferative lupus nephritis: a network meta-analysis of randomized trials. Am J Kidney Dis 70:324\u2013336. https:\/\/doi.org\/10.1053\/j.ajkd.2016.12.008","journal-title":"Am J Kidney Dis"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-07118-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-025-07118-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-07118-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T08:13:46Z","timestamp":1783325626000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-025-07118-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["7118"],"URL":"https:\/\/doi.org\/10.1007\/s00467-025-07118-0","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"assertion":[{"value":"8 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}